Search Results - "Ramos Terrada, Natalia"
-
1
Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study
Published in Clinical kidney journal (01-02-2021)“…Direct-acting antiviral agents (DAAs) have shown high rates of sustained virological response in chronic hepatitis C virus (HCV) infection. However, the…”
Get full text
Journal Article -
2
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
Published in Kidney international (01-06-2020)“…Ravulizumab is a long-acting C5 inhibitor engineered from eculizumab with increased elimination half-life, allowing an extended dosing interval from two to…”
Get more information
Journal Article -
3
5879 PILOT MONITORING STUDY IN PATIENTS WITH DIABETIC KIDNEY DISEASE USING NORA APPLICATION
Published in Nephrology, dialysis, transplantation (14-06-2023)“…Abstract Background and Aims Diabetic Kidney Disease (DKD) is the most common cause of end-stage chronic kidney disease (CKD), conditioning these patients to a…”
Get full text
Journal Article -
4
MO160COVID-19 INFECTION AND ACUTE TUBULOINTERSTITIAL NEPHRITIS
Published in Nephrology, dialysis, transplantation (29-05-2021)“…Abstract Background COVID-19 infection manifests as pneumonia associated with multiple organ failure, and death. Acute kidney injury is a risk factor for…”
Get full text
Journal Article -
5
MO154: Enteric Budesonide in IGAN Nephropathy: A Real World Clinical Practice
Published in Nephrology, dialysis, transplantation (03-05-2022)“…Abstract BACKGROUND AND AIMS The gut–kidney axis seems to have a principal role in immunoglobulin A nephropathy (IgAN) development [1], leading to new…”
Get full text
Journal Article -
6
MO073: Ex Vivo C5B9 Deposition Test as a Diagnostic and Monitoring Tool For Primary and Transplantation Associated AHUS
Published in Nephrology, dialysis, transplantation (03-05-2022)“…Abstract BACKGROUND AND AIMS The atypical hemolytic uremic syndrome (aHUS) is a complement-mediated (CM) ultrarare disease that manifests as thrombotic…”
Get full text
Journal Article -
7
P0306ACUTE KIDNEY INJURY AFTER CHECKPOINT INHIBITOR TREATMENT: FACING THE FUTURE
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims Checkpoint inhibitors (CPI) are used to treat solid organ metastatic malignancies. They act on by triggering a vigorous immune…”
Get full text
Journal Article -
8
P0230IMMUNOSUPPRESSIVE TREATMENT DOES NOT IMPROVE KIDNEY SURVIVAL IN PATIENTS WITH HCV CRYOGLOBULINAEMIA TREATED WITH DIRECT-ACTING ANTIVIRALS
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims Since the introduction of direct-acting antivirals (DAAs), few data have been published about kidney outcome in hepatitis C virus…”
Get full text
Journal Article -
9
MO328: Acute Renal Failure in COVID-19: Aetiology and Renal Evolution. AKI-COVID Registry of the Spanish Society of Nephrology
Published in Nephrology, dialysis, transplantation (03-05-2022)“…Abstract BACKGROUND AND AIMS Acute kidney injury (AKI) has been described as a frequent complication in patients with COVID-19. The incidence of AKI is…”
Get full text
Journal Article -
10
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults
Published in Kidney international reports (01-06-2021)“…Atypical hemolytic uremic syndrome (aHUS) is a rare, complex, multisystem disease of dysregulated complement activity, characterized by progressive thrombotic…”
Get full text
Journal Article